Page 55 - Read Online

Lu et al. Microbiome Res Rep 2024;3:17 https://dx.doi.org/10.20517/mrr.2023.44 Page 11 of 14

brain-gut axis. Neonatology 2019;115:423-31. DOI PubMed PMC
20. Bauer KC, Huus KE, Finlay BB. Microbes and the mind: emerging hallmarks of the gut microbiota-brain axis. Cell Microbiol
2016;18:632-44. DOI PubMed
21. Heinzel S, Aho VTE, Suenkel U, et al. Gut microbiome signatures of risk and prodromal markers of Parkinson disease. Ann Neurol
2021;90:E1-12. DOI
22. Tan AH, Lim SY, Lang AE. The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic. Nat Rev Neurol
2022;18:476-95. DOI PubMed
23. Quigley EMM. The gut-brain axis and the microbiome: clues to pathophysiology and opportunities for novel management strategies
in irritable bowel syndrome (IBS). J Clin Med 2018;7:6. DOI PubMed PMC
24. Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The central nervous system and the gut microbiome. Cell 2016;167:915-
32. DOI PubMed PMC
25. Das De T, Sharma P, Tevatiya S, et al. Bidirectional microbiome-gut-brain-axis communication influences metabolic switch-
associated responses in the mosquito anopheles culicifacies. Cells 2022;11:1798. DOI PubMed PMC
26. Ren Z, Li A, Jiang J, et al. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular
carcinoma. Gut 2019;68:1014-23. DOI PubMed PMC
27. Rager SL, Zeng MY. The gut-liver axis in pediatric liver health and disease. Microorganisms 2023;11:597. DOI PubMed PMC
28. Qin N, Yang F, Li A, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 2014;513:59-64. DOI
29. Forsythe P, Bienenstock J, Kunze WA. Vagal pathways for microbiome-brain-gut axis communication. Adv Exp Med Biol
2014;817:115-33. DOI PubMed
30. Teratani T, Mikami Y, Nakamoto N, et al. The liver-brain-gut neural arc maintains the T cell niche in the gut. Nature
reg
2020;585:591-6. DOI PubMed
31. Dollé JP, Rodgers JM, Browne KD, Troxler T, Gai F, Smith DH. Newfound effect of N-acetylaspartate in preventing and reversing
aggregation of amyloid-beta in vitro. Neurobiol Dis 2018;117:161-9. DOI PubMed PMC
32. Warepam M, Mishra AK, Sharma GS, et al. Brain metabolite, N-acetylaspartate is a potent protein aggregation inhibitor. Front Cell
Neurosci 2021;15:617308. DOI PubMed PMC
33. Veiga-da-Cunha M, Tyteca D, Stroobant V, Courtoy PJ, Opperdoes FR, Van Schaftingen E. Molecular identification of NAT8 as the
enzyme that acetylates cysteine S-conjugates to mercapturic acids. J Biol Chem 2010;285:18888-98. DOI PubMed PMC
34. Wang HX, Wang YP. Gut microbiota-brain axis. Chin Med J 2016;129:2373-80. DOI PubMed PMC
35. Ruggiero DA, Mtui EP, Otake K, Anwar M. Central and primary visceral afferents to nucleus tractus solitarii may generate nitric oxide
as a membrane-permeant neuronal messenger. J Comp Neurol 1996;364:51-67. DOI
36. Mohammadi MS, Thabut D, Cazals-Hatem D, et al. Possible mechanisms involved in the discrepancy of hepatic and aortic
endothelial nitric oxide synthases during the development of cirrhosis in rats. Liver Int 2009;29:692-700. DOI
37. Nandeesha H, Rajappa M, Manjusha J, Ananthanarayanan PH, Kadhiravan T, Harichandrakumar KT. Pentraxin-3 and nitric oxide as
indicators of disease severity in alcoholic cirrhosis. Br J Biomed Sci 2015;72:156-9. DOI PubMed
38. Tse JKY. Gut microbiota, nitric oxide, and microglia as prerequisites for neurodegenerative disorders. ACS Chem Neurosci
2017;8:1438-47. DOI PubMed
39. Williams R. Review article: bacterial flora and pathogenesis in hepatic encephalopathy. Aliment Pharmacol Ther 2007;25:17-22.
DOI PubMed
40. Bajaj JS. The role of microbiota in hepatic encephalopathy. Gut Microbes 2014;5:397-403. DOI PubMed PMC
41. Rai R, Saraswat VA, Dhiman RK. Gut microbiota: its role in hepatic encephalopathy. J Clin Exp Hepatol 2015;5:S29-36. DOI
PubMed PMC
42. Tilg H, Adolph TE, Trauner M. Gut-liver axis: pathophysiological concepts and clinical implications. Cell Metab 2022;34:1700-18.
DOI PubMed
43. Parekh PJ, Balart LA. Ammonia and its role in the pathogenesis of hepatic encephalopathy. Clin Liver Dis 2015;19:529-37. DOI
PubMed
44. Busnelli M, Manzini S, Chiesa G. The gut microbiota affects host pathophysiology as an endocrine organ: a focus on cardiovascular
disease. Nutrients 2019;12:79. DOI PubMed PMC
45. Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: gut microbiota: the neglected endocrine organ. Mol
Endocrinol 2014;28:1221-38. DOI PubMed PMC
46. Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun 2018;9:3294. DOI PubMed PMC
47. Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe
2018;23:716-24. DOI PubMed
48. Kidron H, Repo S, Johnson MS, Salminen TA. Functional classification of amino acid decarboxylases from the alanine racemase
structural family by phylogenetic studies. Mol Biol Evol 2007;24:79-89. DOI PubMed
49. Tillisch K, Labus JS. Neuroimaging the microbiome-gut-brain axis. Adv Exp Med Biol 2014;817:405-16. DOI
50. Prinsloo S, Lyle RR. The microbiome, gut-brain-axis, and implications for brain health. NeuroRegulation 2015;2:158-61. DOI
PubMed PMC
51. Aldridge DR, Tranah EJ, Shawcross DL. Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation. J
Clin Exp Hepatol 2015;5:S7-20. DOI PubMed PMC